Cargando…
A tissue-engineered model of the blood-tumor barrier during metastatic breast cancer
Metastatic brain cancer has poor prognosis due to challenges in both detection and treatment. One contributor to poor prognosis is the blood–brain barrier (BBB), which severely limits the transport of therapeutic agents to intracranial tumors. During the development of brain metastases from primary...
Autores principales: | Linville, Raleigh M., Maressa, Joanna, Guo, Zhaobin, Chung, Tracy D., Farrell, Alanna, Jha, Ria, Searson, Peter C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623725/ https://www.ncbi.nlm.nih.gov/pubmed/37924145 http://dx.doi.org/10.1186/s12987-023-00482-9 |
Ejemplares similares
-
Effects of acute and chronic oxidative stress on the blood–brain barrier in 2D and 3D in vitro models
por: Chung, Tracy D., et al.
Publicado: (2022) -
Tissue-engineered blood-brain barrier models via directed differentiation of human induced pluripotent stem cells
por: Grifno, Gabrielle N., et al.
Publicado: (2019) -
Benchmarking in vitro tissue-engineered blood–brain barrier models
por: DeStefano, Jackson G., et al.
Publicado: (2018) -
The influence of physiological and pathological perturbations on blood-brain barrier function
por: Zhao, Nan, et al.
Publicado: (2023) -
Next-generation in vitro blood–brain barrier models: benchmarking and improving model accuracy
por: Linville, Raleigh M., et al.
Publicado: (2021)